The Trial Innovation Network is a collaborative initiative of the National Center for Advancing Translational Sciences (NCATS) that seeks to address critical roadblocks in clinical trials and accelerate the translation of novel research into clinical practice. Johns Hopkins University and Tufts Medical Center, together with the Institute for Clinical Research and Health Policy Studies (ICRHPS) and Tufts CTSI were awarded a seven-year grant to establish one of three national Trial Innovation Centers (TICs). The TICs, together with a Recruitment Innovation Center (RIC) and the Clinical and Translational Science Award (CTSA) hubs make up the Trial Innovation Network.

Who is eligible?

Investigators from Tufts CTSI partner institutions with ideas for multi-site studies.

Proposal Submissions

The Trial Innovation Network is accepting competitive submissions of requests for research proposal support on an ongoing basis. Selected proposals will receive assistance from national clinical studies experts with developing statistical analysis plans, feasibility analysis, recruitment plans, and guidance on operating a central IRB, among other services.

To learn about services offered by the Trial Innovation Network, and the submission process, please:

Prior to submitting a request for Trial Innovation Network support, investigators must review their study proposals with Tufts CTSI Hub Liaison Team members and avail themselves of available local CTSI protocol development resources. Proposals must be approved by Jonathan Davis, MD, Director of the Trial Innovation Network Hub Liaison Team, before they are submitted to the Trial Innovation Network.

If you are affiliated with Tufts CTSI, please submit a request for support here. Please be sure to select General Consult and use the text box to describe your Trial Innovation Network request.


For more information, please contact:

Jonathan Davis, MD
Director, Trial Innovation Network Hub Liaison Team